欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/2090/001
药品名称Levothyroxine Alapis 100 microgram/ml
活性成分
    • levothyroxine sodium 100.0 µg/ml
剂型Oral drops, solution
上市许可持有人Alapis SA
参考成员国 - 产品名称Netherlands (NL)
Levothyroxine Alapis 100 microgram/ml
互认成员国 - 产品名称
    • Belgium (BE)
    • Bulgaria (BG)
      Levothyroxine Alapis
    • Cyprus (CY)
    • Germany (DE)
      Levothyroxine Alapis 100 microgram/ml Tropfen
    • Greece (GR)
    • Malta (MT)
      Levothyroxine Alapis 100 microgram/ml Oral drops, solution
    • Romania (RO)
      Levotiroxina Alapis 100 micrograme / ml picaturi orale, solutie
    • Portugal (PT)
    • United Kingdom (Northern Ireland) (XI)
许可日期2013/01/14
最近更新日期2023/05/26
药物ATC编码
    • H03AA01 levothyroxine sodium
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase